Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Hetero Drugs Limited - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 25 | Code: MRS - 18624


Global Markets Directs, Hetero Drugs Limited Product Pipeline Review 2014, provides an overview of the Hetero Drugs Limiteds pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hetero Drugs Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Hetero Drugs Limited including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Hetero Drugs Limiteds human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Hetero Drugs Limiteds pipeline products

Reasons to buy

Evaluate Hetero Drugs Limiteds strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Hetero Drugs Limited in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Hetero Drugs Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Hetero Drugs Limited and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hetero Drugs Limited
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Hetero Drugs Limited and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content 

Table of Contents 2
List of Tables 3
List of Figures 3
Hetero Drugs Limited Snapshot 4
Hetero Drugs Limited Overview 4
Key Information 4
Key Facts 4
Hetero Drugs Limited- Research and Development Overview 5
Key Therapeutic Areas 5
Hetero Drugs Limited- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
Pipeline Products- Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
Hetero Drugs Limited- Pipeline Products Glance 11
Hetero Drugs Limited- Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Hetero Drugs Limited- Early Stage Pipeline Products 12
Discovery Products/Combination Treatment Modalities 12
Hetero Drugs Limited- Drug Profiles 13
rituximab biosimilar 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Small Molecules for Diabetes 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Small Molecules for Hepatitis C 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecules for HIV 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Hetero Drugs Limited- Pipeline Analysis 17
Hetero Drugs Limited- Pipeline Products by Target 17
Hetero Drugs Limited- Pipeline Products by Route of Administration 18
Hetero Drugs Limited- Pipeline Products by Molecule Type 19
Hetero Drugs Limited- Pipeline Products by Mechanism of Action 20
Hetero Drugs Limited- Dormant Projects 21
Hetero Drugs Limited- Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22

Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25

List of Tables

Hetero Drugs Limited, Key Information 4
Hetero Drugs Limited, Key Facts 4
Hetero Drugs Limited- Pipeline by Indication, 2014 6
Hetero Drugs Limited- Pipeline by Stage of Development, 2014 7
Hetero Drugs Limited- Monotherapy Products in Pipeline, 2014 8
Hetero Drugs Limited- Partnered Products in Pipeline, 2014 9
Hetero Drugs Limited- Partnered Products/ Combination Treatment Modalities, 2014 10
Hetero Drugs Limited- Phase III, 2014 11
Hetero Drugs Limited- Discovery, 2014 12
Hetero Drugs Limited- Pipeline by Target, 2014 17
Hetero Drugs Limited- Pipeline by Route of Administration, 2014 18
Hetero Drugs Limited- Pipeline by Molecule Type, 2014 19
Hetero Drugs Limited- Pipeline Products by Mechanism of Action, 2014 20
Hetero Drugs Limited- Dormant Developmental Projects,2014 21
Hetero Drugs Limited, Other Locations 22
Hetero Drugs Limited, Subsidiaries 23

List of Figures

Hetero Drugs Limited - Pipeline by Top 10 Indication, 2014 6
Hetero Drugs Limited - Pipeline by Stage of Development, 2014 7
Hetero Drugs Limited - Monotherapy Products in Pipeline, 2014 8
Hetero Drugs Limited - Pipeline by Top 10 Molecule Type, 2014 19

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing